Labshake search
Citations for R&D Systems :
501 - 550 of 3986 citations for 2' Chloro 4 5 5 dimethyl 1 3 dioxan 2 yl butyrophenone since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2024Quote: ... and 100 U/ml IL-2 (R&D Systems, Minneapolis, MN). NK-92 cells were passaged in 2–3 day interval to maintain the cell density at 2.5 × 105 – 1 × 106 cells/ml ...
-
bioRxiv - Immunology 2024Quote: Recombinant human IL-2 (Proleukin) was purchased from R&D Systems or obtained from the National Cancer Institute’s Biological Research Branch ...
-
bioRxiv - Bioengineering 2024Quote: ... recombinant human fibroblastic growth factor basic (FGF-2, R&D Systems), dimethyl sulfoxide (anhydrous ...
-
bioRxiv - Bioengineering 2024Quote: ... BMP-2 Quantikine ELISA Kit (biotechne®, R&D systems, UK); Alcian blue 8X ...
-
bioRxiv - Bioengineering 2023Quote: Recombinant SARS-CoV-2 proteins were purchased from R&D systems. For vaccination ...
-
bioRxiv - Immunology 2023Quote: ... Mouse Lipocalin-2/NGAL DuoSet ELISA kit by R&D Systems was used following the manufacturer’s protocol.
-
bioRxiv - Immunology 2023Quote: ... 10 U/mL human rIL-2 (202-IL, R&D Systems) was added to expand the T cells ...
-
bioRxiv - Bioengineering 2023Quote: ... BMP-2 Quantikine ELISA Kit (biotechne®, R&D systems, UK); alcian blue 8X ...
-
bioRxiv - Cell Biology 2023Quote: ... and 20 ng/ml FGF-2 (R&D Systems, Minneapolis, MN). Media were changed daily ...
-
bioRxiv - Cancer Biology 2023Quote: ... homogenized and digested in Cell Lysis Buffer #2 (R&D Systems) containing protease inhibitors on ice for 1 hour ...
-
bioRxiv - Cancer Biology 2024Quote: ... type 2 (∼4mg/ml, Cultrex, RGF BME, Type2; R&D Systems) and maintained in LO complete media which consists of LO basic media -Advanced DMEM/F12 media (Thermo Fisher) ...
-
bioRxiv - Synthetic Biology 2024Quote: ... and 30 IU/mL recombinant human IL-2 (R&D Systems). Following isolation ...
-
bioRxiv - Systems Biology 2024Quote: ... Type 2 (BME; R&D Systems, Minneapolis, MN; 3533-001-02) and droplets of 60μL were plated onto 24-well plates ...
-
bioRxiv - Neuroscience 2024Quote: ... USA]) and growth factors (LM-22A4[2 mM, R&D Systems, Minneapolis ...
-
bioRxiv - Bioengineering 2024Quote: ... and 40 IU IL-2 (R&D Systems #202-IL-10). All cells were cultured at 37°C ...
-
bioRxiv - Immunology 2024Quote: ... or BME (Cultrex® RGF BME Type 2, R&D systems). GrowDex (supplied as a suspension of 1.5% nanofibrillar cellulose in 98.5% ultra-pure water ...
-
bioRxiv - Cancer Biology 2023Quote: Ascites collected from RD and IF mice (n=4/ group) were pooled and diluted 1:3 and applied in the adipokine array (ARY-013, R&D systems, Minneapolis, MN, USA). The proteome profiler adipokine array detects 38 adipokines (Table S4 ...
-
bioRxiv - Molecular Biology 2020Quote: Randomly selected sections coming from ovarian tissue of least 3 different individuals were used for immunohistochemistry for Anti-active Caspase-3 (AC-3, 1:1000, AF-835, R&D Systems), γH2AX (1:250 IHC-00059 ...
-
bioRxiv - Cell Biology 2020Quote: ... and HHIP (Cat#9280-HP-050; R&D Systems; used 5 μg/mL) were added to the media after 48 hours and replenished in every media change ...
-
bioRxiv - Neuroscience 2020Quote: ... and 5 ng/mL of basic fibroblast growth factor (bFGF; R&D Systems) on 0.1% gelatin coated dishes with irradiated mouse embryonic fibroblast (iMEFs).
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D Systems, Minneapolis, MN, USA) and antibiotics/antimycotics (ThermoFisher Scientific ...
-
bioRxiv - Bioengineering 2021Quote: ... Wnt was inactivated by adding XAV939 (5 μmol/L, R&D Systems 3748) in BPEL ...
-
bioRxiv - Cell Biology 2021Quote: ... and 5 ng/mL TGF-β (R&D Systems, cat# 240-B-002). To test the effect of FYN depletion on collagen deposition ...
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D Systems, Minneapolis, MN, USA) and antibiotics/antimycotics (ThermoFisher Scientific ...
-
bioRxiv - Bioengineering 2021Quote: ... Wnt was inactivated by adding XAV939 (5 μmol/L, R&D Systems 3748) in BPEL ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D Systems, Minneapolis, MN, USA) and antibiotics/antimycotics (Fisher Scientific ...
-
bioRxiv - Immunology 2020Quote: ... injection of AMD3100 (5 mg/kg in 200 µl saline; R&D Systems) were used to stimulate acute inflammation in the cremaster muscle and to mobilize neutrophils ...
-
bioRxiv - Immunology 2022Quote: ... and 5 ng/ml TGF-β1 (R&D Systems, Bio-Techne, Wiesbaden, Germany) for 72 hours.
-
bioRxiv - Cancer Biology 2022Quote: ... 5 μg/mL Tenascin-C (Cat no. 3358-TC-050, R&D Systems) coated ...
-
bioRxiv - Cancer Biology 2023Quote: ... 5 µg control IgG or anti-LRG1 antibodies (both from R&D Systems) were added to 500 μl of 3X CM (1000 μg total proteins ...
-
bioRxiv - Biophysics 2023Quote: ... 5 ng/ml of recombinant mouse interleukin-1β (IL-1β, R&D Systems), and 100 ng/ml of recombinant mouse interferon-γ (IFN-γ ...
-
bioRxiv - Bioengineering 2023Quote: ECFCs and PRECs were treated with 5 nM Fc Chimera (R&D Systems) or 100 ug/mL NRP-1 Antibody (R&D Systems ...
-
bioRxiv - Cell Biology 2024Quote: ... or recombinant FGF9 (5-25 ng/ml, R&D Systems, INC, Minneapolis, MN). After 24 ...
-
bioRxiv - Bioengineering 2024Quote: ... 5 ng/mL R-Spondin1 (R-spo1; R&D systems; 4645-RS/CF), and 1% B27 supplement (Gibco ...
-
bioRxiv - Developmental Biology 2024Quote: ... cultures were maintained in media containing 5 ng/ml FGF2 (R&D Systems), 15 ng/ml VEGF (Peprotech) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5% BSA and VisUBlock Mouse on Mouse Blocking Reagent (R&D Systems, VB001). Primary and secondary antibodies were diluted in 0.1% saponin ...
-
bioRxiv - Immunology 2023Quote: ... Subsequently the cells were rested and expanded in kool aid complete media for 2 days supplemented with 100 U/mL recombinant Human IL-2 (R&D Systems Cat# 202-IL-010/CF). Subsequently ...
-
bioRxiv - Bioengineering 2024Quote: ... PBMCs were stimulated for 2 days with anti-CD3/anti-CD28 T cell activation beads (Thermo, catalog no. 11131D) in the presence of interleukin-2 (IL-2; 40 IU/ml; R&D Systems, catalog no. 202-IL-010) in complete T cell media and incubated at 37°C ...
-
bioRxiv - Microbiology 2021Quote: ... serum was incubated for 2 h with polyclonal sheep IgG anti-LL-37 (2.5 – 20 μg ml−1; R&D Systems) or anti-hNP-1 (2.5 – 20 μg ml−1 ...
-
bioRxiv - Microbiology 2023Quote: ... Relative expression was calculated against a 2% input control.Samples were then normalized to uninfected cells stimulated with universal type 1 interferon (R&D Systems).
-
bioRxiv - Neuroscience 2024Quote: ... and reseeded on laminin-521 coated plates at a split ratio of 1:2.5 in CPN medium supplemented with 20 ng/mL fibroblast growth factor 2 (FGF2; R&D Systems) and 10 µM Y-27632 ...
-
bioRxiv - Cancer Biology 2021Quote: ... active caspase-3 (R&D Systems AF835; 1:50), and Vimentin (CST 5741 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and caspase-3 (1:2000, AF835, R&D Systems) on a Ventana Benchmark Ultra automated staining system (Roche) ...
-
bioRxiv - Developmental Biology 2023Quote: ... VEGFR-3 (AF349, R&D Systems, 1:100, RRID:AB_355314), Coup-TF2 (EPR18443 ...
-
bioRxiv - Cell Biology 2023Quote: ... GLI-3 (AF3690, R&D Systems, dilution 1:500), RAB11FIP5 (14594-1-AP ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197), anti-Hsp70 (1:300 ...
-
bioRxiv - Cell Biology 2023Quote: ... and 1 ng/ml IL-3 (R&D Systems) to induce cell proliferation ...
-
bioRxiv - Cancer Biology 2022Quote: ... bioreactor media were either left untreated or supplemented with anti– Siglec-9 antibody (5 μg mL-1; clone 191240, #MAB1139-500, R&D systems, USA). On day 5 ...
-
bioRxiv - Cell Biology 2024Quote: ... 400 µL of a 5 µg mL-1 biotinylated polyclonal Goat anti-Vascular Endothelial Growth Factor IgG solution in PBS (R&D Systems, USA) was added to CellStudio substrates containing streptavidin coated microbeads patterns (500 nm diameter beads ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 5% fetal Bovine serum (Hyclone, #SH300084) and treatment with 2.5 ng/ml of recombinant Human TGF-β 1 Protein (R&D systems, #RDS240B002) for maximum of 18 days ...